Comparison of antioxidant activity of cilnidipine and amlodipine

Kidney International

Volumn 76, Issue 2, 2009, Pages 230-231

  Hishikawa, Keiichi ^a   Takase, Osamu ^a   Idei, Mana ^a   Fujito, Toshiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CILNIDIPINE; IONOMYCIN;

ANTIOXIDANT ACTIVITY; CELL STIMULATION; CONCENTRATION RESPONSE; HUMAN; LETTER; MESANGIUM CELL; PRIORITY JOURNAL;

EID: 67649884761     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.146     Document Type: Letter

References (4)

1. Fujita T, Ando K, Nishimura H et al. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 2007; 72: 1543-1549.
2. Nistala R, Whaley-Connell A, Sowers JR. Redox control of renal function and hypertension. Antioxid Redox Signal 2008; 10: 2047-2089.
3. Mak IT, Weglicki WB. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990; 66: 1449-1452.
4. Uesawa Y, Mohri K. Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice. Yakugaku Zasshi 2008; 128: 117-122.